However, considering its role in the regulation of multiple proliferative and anti‐apoptotic signaling pathways, therapeutic strategies based on the down‐modulation of ZNF224 could constitute an attractive adjuvant in the treatment of melanoma. The gene discussed is ZNF224; the disease is melanoma.